Council Members in this Study Group: 52
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
Sanjay Rao, MDMedical Director
Lakeside Eye Clinic ![]()
Sanjay Rao, MD, is the Medical Director and Director of Cornea and Refractive Surgery at the Lakeside Eye Clinic in Chicago. He was previously the Director of Cornea and Refractive Surgery at the University of Chicago. He has clinical expertise in diseases of the cornea and is a high volume cataract,...
Gaurav Shah, MDAssociate Professor of Ophthalmology
WASHINGTON UNIVERSITY MEDICAL CENTER ![]()
Gaurav Shah, MD, is an Associate Professor of Ophthalmology at the Washington University Medical Center in Missouri. He is a national expert in the care of patients with diabetic retinopathy/diabetic macular edema, age-related macular degeneration, retinal detachments, and the economics of retinalhealth...
Vincent de Luise, MDAssistant Clinical Professor of Ophthalmology
YALE UNIVERSITY ![]()
Vincent de Luise, MD, FACS, is an Assistant Clinical Professor of Ophthalmology at Yale University and the University of Connecticut Health Center. He is the Head of Cornea Service at OptiCare Eye Health Center, Waterbury CT, where he also has his private practice. Dr. de Luise is Education Chair of...
Barry Schechter, MDDirector of Corneal and External Diseases
FLORIDA EYE MICROSURGICAL INSTITUTE INC ![]()
Barry Schechter, MD, is the Director of Department of Cornea and External Disease at Florida Eye Microsurgical Institute. Dr. Schechter's practice involves diseases of the ocular surface including dry eyes, allergies, infection; the latest in corneal, refractive, and cataract surgery, and glaucoma....
Owner and Clinical Director
Coastal Vision ![]()
Hal Breedlove, OD, is the Owner and Clinical Director of Coastal Vision, a five Optometrist practice in Virginia Beach, Chesapeake, and Norfolk Virginia. In practice for over 26 years, he has expertise in a many areas of vision research, patient care, practice management, and optical (contact lenses,...
Steve Rubinstein, ODOptometrist
Sound Shore Vision Care ![]()
Steve Rubinstein, OD, is a Clinical Optometrist at Diamond District Eye Associates and Sound Shore Vision Center, office based practices in New York. Dr. Rubinstein has a biochemical background. He has won the Frank R. Blood award by the Society of Toxicology for the best paper in this peer reviewed...
President
Ophthalmology Consultants ![]()
Andrew Dahl, MD, FACS, FAAO, is the President of Ophthalmology Consultants in New York. He was also Principal Investigator for Hudson Valley Eye Research Foundation and has conducted numerous clinical trials. Dr. Dahl is a board-certified Ophthalmologist/Ophthalmic Surgeon. He has expertise in allaspects...
Eric Donnenfeld, MDCo-Chairman of Cornea
NASSAU UNIVERSITY OF MEDICAL CENTER ![]()
Eric Donnenfeld, MD, is a Clinical Professor of Ophthalmology at New York University and Trustee at Dartmouth Medical School, since 1994. Dr. Donnenfeld is a Co-Chairman of Cornea at Nassau University Medical Center. He is also the Surgical Director of Lions Eye Bank for Long Island, the National Medical...
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Lumigan X EU Committee Recomendation
October 27, 2009
Andrew Dahl, MD, President , Ophthalmology Consultants
EU committee backs marketing approval of Lumigan | www.pharmabiz.com
The Committee for Medicinal Products for Human Use (CHMP) of the European Union has recommended granting a Marketing Authorization for a new version of Allergan's Lumigan (bimatoprost ophthalmic solution). This new version will be marketed as Lumigan-X after approval. Lumigan X offers Allergan anew...
NO BRAINER: Genentech Prefers to Promote Lucentis over Avastin for Wet ARMD
October 7, 2009
Genentech revisits plan for Avastin | www.sfgate.com
It does not require a lot of ophthalmic and business savy to understand why a company rather promote a drug that costs more than 20 times more to treat the same medical condition.
Contact Lens Nirvana: Hyperpermeable One Day
October 2, 2009
Steve Rubinstein, OD, Optometrist, Sound Shore Vision Care
Hobby assists Irish strategy | www.opticianonline.net
This article describes resources being put into place to mass produce the first commercially available silicon hydrogel one day disposable contact lens in the USA by Johnson & Johnson's Vistakon division.
Alcon, Novartis (Ciba Vision), Astra-Zeneca working on ocular medications?
July 23, 2009
Steve Rubinstein, OD, Optometrist, Sound Shore Vision Care
Alcon Signs Agreement With AstraZeneca On Eye Drug Development | www.pharmaceutical-business-review.com
This agreement seems to allow Alcon Laboratories, Inc and Astra-Zeneca to work together to produce ocular medications. What it doesn't say is that they can also use Ciba Vision's resources in the near future.
Technical analysis of multifocal lens implants (IOLs) and astigmatism lens implants (Toric IOLs)
July 14, 2009
Vincent de Luise, MD, Assistant Clinical Professor of Ophthalmology , YALE UNIVERSITY
FDA Approves Alcon's AcrySof® IQ ReSTOR® +3.0 D Intraocular Lens - New Lens Corrects For Cataracts With Presbyopia | www.medicalnewstoday.com
There is a sea-change in cataract/lens implant (IOL) surgery. More than ever before, patients with cataracts want to able to see well without the need for glasses or contact lenses. Standard IOLs give very good vision, but many patients have pre-existing astigmatism and need...